New RSV vaccine for babies (nirsevimab, aka Beyfortus), recommended for all infants <8 months entering RSV season this Oct.
Every pediatrician will tell you that during residency they cared for hundreds of kids w/ RSV. This huge advance will save lives. https://t.co/Y1YyFDzzgj
ACTIVE-AF trial @PrashSanders & colleagues: Regular physical activity of aerobic interval exercise of up to 3.5 hours a week over 6 months could significantly:
⬇️ Afib burden
⬇️ symptom severity
☝️ 120 pts randomized 1:1
➡️ https://t.co/iOPAFslHwJ
#CardioTwitter#EPeeps#MedEd
You'll ask a grad student what they do for fun and they'll list what's obviously a collection of coping mechanisms and then just continue the conversation